Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolv Technologies Holdings, Inc.EVLV · Entity 5017 | Chief Revenue Officer | December 19, 2023 | December 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolv Technologies Holdings, Inc.
Report date December 19, 2023 · Filed December 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 38,832 |
Ending reported balance
After 2023-12-19 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-12-19 · Exercise / conversion · Acquired 30,000 · Balance 68,832 Row 2 · 2023-12-19 · Sale · Disposed 30,000 · Balance 38,832 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.42 · Expires 2031-01-10 | Direct | 845,540 |
Reported balance
After 2023-12-19 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-12-19 · Exercise / conversion · Disposed 30,000 · Balance 845,540 F2: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023.
F2: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2022 Filed Dec 5, 2022 14:15 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-22-031320 · wf-form4_167024974485015.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 999,895 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 14:15 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $3.39 | $33,887.00 |
DisclosureSEC source: 0001628280-22-031320 · wf-form4_167024974485015.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.30 to $3.47. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 14:15 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-22-031320 · wf-form4_167024974485015.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:08 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-22-030169 · wf-form4_166863648978046.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,009,895 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:08 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $3.72 | $37,195.00 |
DisclosureSEC source: 0001628280-22-030169 · wf-form4_166863648978046.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.51 to $3.87. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:08 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-22-030169 · wf-form4_166863648978046.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:31 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-22-028233 · wf-form4_166750749629225.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,019,895 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:31 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $2.91 | $29,137.00 |
DisclosureSEC source: 0001628280-22-028233 · wf-form4_166750749629225.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.88 to $3.00. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:31 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-22-028233 · wf-form4_166750749629225.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 14, 2022 Filed Oct 18, 2022 10:39 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-22-026529 · wf-form4_166608952618560.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,029,895 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| October 14, 2022 Filed Oct 18, 2022 10:39 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $2.37 | $23,691.00 |
DisclosureSEC source: 0001628280-22-026529 · wf-form4_166608952618560.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.34 to $2.45. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 14, 2022 Filed Oct 18, 2022 10:39 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-22-026529 · wf-form4_166608952618560.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:22 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-22-025987 · wf-form4_166491855290490.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,039,895 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:22 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $2.07 | $20,671.00 |
DisclosureSEC source: 0001628280-22-025987 · wf-form4_166491855290490.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.13. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:22 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-22-025987 · wf-form4_166491855290490.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 20:26 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 176 | $2.10 | $369.60 |
DisclosureSEC source: 0001104659-22-102691 · tm2226581-2_4seq1.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324 F2 · kind: The sale reported in the Form 4 was effected pursuant to a standing Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported RSUs. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.14. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:26 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-102691 · tm2226581-2_4seq1.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On September 27, 2021, the reporting person was granted 500 restricted stock units ("RSU"), vesting on September 21, 2022. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F1 · derivative.exercise_date: On September 27, 2021, the reporting person was granted 500 restricted stock units ("RSU"), vesting on September 21, 2022. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F1 · derivative.expiration_date: On September 27, 2021, the reporting person was granted 500 restricted stock units ("RSU"), vesting on September 21, 2022. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:26 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-102691 · tm2226581-2_4seq1.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On September 27, 2021, the reporting person was granted 500 restricted stock units ("RSU"), vesting on September 21, 2022. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| September 15, 2022 Filed Sep 17, 2022 00:51 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-22-025092 · wf-form4_166337585859758.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,049,895 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| September 15, 2022 Filed Sep 17, 2022 00:51 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $2.35 | $23,520.00 |
DisclosureSEC source: 0001628280-22-025092 · wf-form4_166337585859758.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.29 to $2.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 15, 2022 Filed Sep 17, 2022 00:51 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-22-025092 · wf-form4_166337585859758.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 22:07 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-22-024301 · wf-form4_166215641193570.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,059,895 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 22:07 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $2.13 | $21,265.00 |
DisclosureSEC source: 0001628280-22-024301 · wf-form4_166215641193570.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.08 to $2.22. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 22:07 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-22-024301 · wf-form4_166215641193570.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:13 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-22-023059 · wf-form4_166068800415484.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,069,895 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:13 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $3.28 | $32,758.00 |
DisclosureSEC source: 0001628280-22-023059 · wf-form4_166068800415484.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:13 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-22-023059 · wf-form4_166068800415484.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 20:09 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-22-020600 · wf-form4_165955736902074.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,079,895 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 20:09 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $2.64 | $26,432.00 |
DisclosureSEC source: 0001628280-22-020600 · wf-form4_165955736902074.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.60 to $2.70. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 20:09 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-22-020600 · wf-form4_165955736902074.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2022 Filed Jul 18, 2022 20:54 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-22-019059 · wf-form4_165817766112818.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,089,895 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| July 15, 2022 Filed Jul 18, 2022 20:54 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $2.46 | $24,614.00 |
DisclosureSEC source: 0001628280-22-019059 · wf-form4_165817766112818.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 17, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.41 to $2.62. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2022 Filed Jul 18, 2022 20:54 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001628280-22-019059 · wf-form4_165817766112818.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:32 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001104659-22-077723 · tm2218267-3_4seq1.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,099,895 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:32 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $2.58 | $25,839.00 |
DisclosureSEC source: 0001104659-22-077723 · tm2218267-3_4seq1.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.52 to $2.63. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:32 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001104659-22-077723 · tm2218267-3_4seq1.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:30 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001104659-22-070558 · tm2218267-1_4seq1.xml · derivative · entry 3 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,109,895 Underlying: Class A Common Stock · 10,000 shares Expires 2031-01-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:30 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 10,000 | $3.14 | $31,379.00 |
DisclosureSEC source: 0001104659-22-070558 · tm2218267-1_4seq1.xml · nonDerivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.06 to $3.24. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:30 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 10,000 | $0.42 | $4,200.00 |
DisclosureSEC source: 0001104659-22-070558 · tm2218267-1_4seq1.xml · nonDerivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:13 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 269,396 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001104659-22-030218 · tm228072-2_4seq1.xml · derivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,396 Underlying: Class A Common Stock · 269,396 shares Expires 2032-02-29 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the underlying shares on March 1, 2023 and in 12 equal quarterly installments thereafter. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:13 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 179,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-030218 · tm228072-2_4seq1.xml · derivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,083 Underlying: Class A Common Stock · 179,083 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2023. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2022 Filed Sep 16, 2022 00:30 UTC Amendment | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 269,396 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0001628280-22-025041 · wf-form4a_166328823000176.xml · derivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,396 Underlying: Class A Common Stock · 269,396 shares Expires 2032-02-29 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the underlying shares on March 1, 2023 and in 12 equal quarterly installments thereafter. Read SEC document |
| September 27, 2021 Filed Sep 28, 2021 20:17 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-120238 · tm2128583-2_4seq1.xml · derivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Class A Common Stock · 500 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:09 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantPerformance Rights · Derivative | 129,700 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094064 · tm2122604-15_4seq1.xml · derivative · entry 2 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,700 Underlying: Class A Common Stock · 129,700 shares Expires not disclosed F3 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F1 · shares: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). F3 · price: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F3 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F3 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:09 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 1,119,895 | Not disclosed Strike: $0.42 | Not disclosed |
DisclosureSEC source: 0001104659-21-094064 · tm2122604-15_4seq1.xml · derivative · entry 1 DeRosa Anthony John · CIK 0001868397 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119,895 Underlying: Class A Common Stock · 1,119,895 shares Expires 2031-01-10 F1 · shares: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). F1 · price: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.